Ian Dixon
Follow
Get notifications in MyBN when activity occurs.
Ian Dixon
Co-Founder / Cynata Therapeutics
Most Notable Role
Dr Ian Dixon co-founded Cynata Inc in 2011, founded Exopharm in 2013 and is a co-inventor of its LEAP Technology.
Dr Dixon has technical and entrepreneurial background in founding, building and running technology-based companies; in recognising the potential commercial value of early-stage drug development; and in understanding the challenges involved in drug development.
Dr Dixon has technical and entrepreneurial background in founding, building and running technology-based companies; in recognising the potential commercial value of early-stage drug development; and in understanding the challenges involved in drug development.
Lists and Charts
Total Shareholder Return as at 29/02/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 548th | CD Private Equity Fund I | 8% | 14% |
| 918th | Imperial Pacific | -13% | 7% |
| 1052nd | Exopharm | -22% | -52% |
| 1066th | Kaili Resources | -23% | -23% |
| 1651st | Native Mineral Resources Holdings | -63% |
1790 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 893rd |  | Exopharm | $3.4m |
| 1051st | | Kaili Resources | $425k |
| 1052nd | | CD Private Equity Fund I | $422k |
| 1055th | | Native Mineral Resources Holdings | $408k |
| 1056th | | Imperial Pacific | $395k |
1330 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Collapse All Lists and Charts
Person Activity
| NEW ROLE: Co-Founder, Cynata Therapeutics | 20 Jan 2021 |
| NEW ROLE: Founder, Non-Executive Director, Nyrada Inc | 03 Nov 2020 |
| NEW ROLE: Managing Director, Exopharm | 03 Nov 2020 |
